Amyloid b-peptide (Ab)-induced cell death may involve activation of the E2F-1 transcription factor and other cell cyclerelated proteins. In previous studies, we have shown that tauroursodeoxycholic acid (TUDCA), an endogenous bile acid, modulates Ab-induced apoptosis by interfering with crucial events of the mitochondrial pathway. In this study, we examined the role of E2F and p53 activation in the induction of apoptosis by Ab, and investigated novel molecular targets for TUDCA. The results showed that despite Bcl-2 up-regulation, PC12 neuronal cells underwent significant apoptosis after incubation with the active fragment Ab (25-35), as assessed by DNA fragmentation, nuclear morphology and caspase-3-like activation. In addition, transcription through the E2F-1 promoter was significantly induced and associated with loss of the retinoblastoma protein. In contrast, levels of E2F-1, p53 and Bax proteins were markedly increased. Overexpression of E2F-1 in PC12 cells was sufficient to induce p53 and Bax proteins, as well as nuclear fragmentation. Notably, TUDCA modulated Ab-induced apoptosis, E2F-1 induction, p53 stabilization and Bax expression. Further, TUDCA protected PC12 cells against p53-and Bax-dependent apoptosis induced by E2F-1 and p53 overexpression, respectively. In conclusion, the results demonstrate that Ab-induced apoptosis of PC12 cells proceeds through an E2F-1/p53/Bax pathway, which, in turn, can be specifically inhibited by TUDCA, thus underscoring its potential therapeutic use. Keywords: Bcl-2 proteins, bile acids, caspases, neuroprotection, retinoblastoma protein. Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive memory loss and deficit of cognitive skills. The pathological hallmarks of AD include selective damage to synapses and neurons, neurofibrillary tangles, activated glia and presence of senile plaques (Selkoe 2001). Amyloid b-peptide (Ab) is the major constituent of senile or amyloid plaques found in the brains of AD patients. Ab is derived from the processing of the amyloid precursor protein (Haass and Selkoe 1993), and is thought to play a critical role in the onset or progression of AD. Previous studies have shown that Abinduced cytotoxicity involves oxidative stress, inflammation and perturbation of calcium homeostasis (Selkoe 2001). In fact, both necrosis and apoptosis are thought to occur in primary neurons and neuronal cell lines after exposure to Ab, as well as in brains of AD patients (Yankner et al. 1990;Loo et al. 1993;Behl et al. 1994;Su et al. 1994;Mark et al. 1995).Cell cycle-related molecules are up-regulated in postmitotic neurons within affected brain regions during AD (McShea et al. 1997;Vincent et al. 1997;Busser et al. 1998). However, it is unclear whether deregulation of cell cycle events contributes to neurodegeneration in AD. E2F-1 Received February 11, 2004; revised manuscript received March 18, 2004; accepted March 19, 2004. Address correspondence and reprint requests to C. M. P. Rodrigues, Centro de Patogénese Molecul...